Large-scale assessment of pros and cons of autopsy-derived or tumor-matched tissues as the norms for gene expression analysis in cancers

[1]  A. Buzdin,et al.  Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers , 2023, Frontiers in Immunology.

[2]  M. Suntsova,et al.  Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways. , 2023, DNA repair.

[3]  R. Schilsky,et al.  A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology , 2023, Therapeutic advances in medical oncology.

[4]  M. Ferrarini,et al.  Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia , 2022, International journal of molecular sciences.

[5]  N. Sata,et al.  Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer , 2022, Frontiers in Immunology.

[6]  Nicolas Borisov,et al.  Transcriptomic Harmonization as the Way for Suppressing Cross-Platform Bias and Batch Effect , 2022, Biomedicines.

[7]  M. Sorokin,et al.  Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors , 2022, The Journal of biological chemistry.

[8]  M. Suntsova,et al.  Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling , 2022, International journal of molecular sciences.

[9]  Nicolas Borisov,et al.  OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization , 2022, Computational and structural biotechnology journal.

[10]  Nicolas Borisov,et al.  Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer , 2022, Frontiers in Molecular Biosciences.

[11]  Ying Ma,et al.  Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes , 2022, Frontiers in Oncology.

[12]  C. Lanni,et al.  Molecular regulations of circadian rhythm and implications for physiology and diseases , 2022, Signal Transduction and Targeted Therapy.

[13]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[14]  F. Rodrigues-Soares,et al.  Influence of GSTM1, GSTT1, and GSTP1 genetic polymorphisms on disorders in transplant patients: a systematic review , 2021, Drug metabolism and personalized therapy.

[15]  Gloria M. Sheynkman,et al.  Full-length transcript sequencing of human and mouse cerebral cortex identifies widespread isoform diversity and alternative splicing , 2021, Cell reports.

[16]  R. Epand,et al.  Plasmalogens and Chronic Inflammatory Diseases , 2021, Frontiers in Physiology.

[17]  M. Suntsova,et al.  Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes , 2021, Oncogene.

[18]  L. Feuk,et al.  Transcriptome Analysis of Post-Mortem Brain Tissue Reveals Up-Regulation of the Complement Cascade in a Subgroup of Schizophrenia Patients , 2021, Genes.

[19]  L. Marchionni,et al.  RNA‐sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas , 2021, Brain pathology.

[20]  B. Tannous,et al.  Olfactory receptor 5B21 drives breast cancer metastasis , 2021, iScience.

[21]  H. Werner,et al.  The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway , 2021, Cells.

[22]  A. Kommadath,et al.  Evaluation of RNA quality and functional transcriptome of beef longissimus thoracis over time post-mortem , 2021, PloS one.

[23]  M. Suntsova,et al.  DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles , 2021, Heliyon.

[24]  C. Vollmers,et al.  A conserved long noncoding RNA, GAPLINC, modulates the immune response during endotoxic shock , 2021, Proceedings of the National Academy of Sciences.

[25]  Nicolas Borisov,et al.  Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways , 2021, Frontiers in Genetics.

[26]  T. Putoczki,et al.  JAK-STAT Signalling Pathway in Cancer , 2020, Cancers.

[27]  M. Suntsova,et al.  Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels , 2020, Biochemistry (Moscow).

[28]  M. Suntsova,et al.  Clinical use of RNA sequencing and oncobox analytics to predict personalized targeted therapeutic efficacy. , 2020 .

[29]  G. Nowicka,et al.  Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions , 2020, Cancers.

[30]  M. Suntsova,et al.  RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens , 2020, Biomedicines.

[31]  Tim O. Nieuwenhuis,et al.  Consistent RNA sequencing contamination in GTEx and other data sets , 2020, Nature Communications.

[32]  Ye Wang,et al.  Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology , 2020, Frontiers in Oncology.

[33]  L. Roshangar,et al.  Tumor microenvironment complexity and therapeutic implications at a glance , 2020, Cell Communication and Signaling.

[34]  M. Suntsova,et al.  RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer , 2020, Cold Spring Harbor molecular case studies.

[35]  M. Sorokin,et al.  RNA sequencing for research and diagnostics in clinical oncology. , 2020, Seminars in cancer biology.

[36]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[37]  L. Zwiebel,et al.  Olfactory receptor gene abundance in invasive breast carcinoma , 2019, Scientific Reports.

[38]  M. Suntsova,et al.  Atlas of RNA sequencing profiles for normal human tissues , 2019, Scientific Data.

[39]  J Jack Lee,et al.  Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial , 2019, Nature Medicine.

[40]  F. Mollinedo.  Neutrophil Degranulation, Plasticity, and Cancer Metastasis. , 2019, Trends in immunology.

[41]  Nicolas Borisov,et al.  Shambhala: a platform-agnostic data harmonizer for gene expression data , 2019, BMC Bioinformatics.

[42]  J. Lunceford,et al.  T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Kimberly J. Johnson,et al.  Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases , 2018, British Journal of Cancer.

[44]  Amir Samii,et al.  Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs. , 2018, Seminars in cancer biology.

[45]  Khaled Seidi,et al.  Tumor target amplification: Implications for nano drug delivery systems , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[46]  M. de la Guardia,et al.  Modulating tumor hypoxia by nanomedicine for effective cancer therapy , 2018, Journal of cellular physiology.

[47]  Dmitri D. Pervouchine,et al.  The effects of death and post-mortem cold ischemia on human tissue transcriptomes , 2018, Nature Communications.

[48]  J. Menet,et al.  Regulation of circadian clock transcriptional output by CLOCK:BMAL1 , 2018, PLoS genetics.

[49]  T. Nakaki,et al.  Neuroprotection afforded by circadian regulation of intracellular glutathione levels: A key role for miRNAs☆ , 2017, Free radical biology & medicine.

[50]  A. Butte,et al.  Comprehensive analysis of normal adjacent to tumor transcriptomes , 2017, Nature Communications.

[51]  Ence Yang,et al.  Systematic analysis of gene expression patterns associated with postmortem interval in human tissues , 2017, Scientific Reports.

[52]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.

[53]  N. Zarghami,et al.  Tumor vascular infarction: prospects and challenges , 2017, International Journal of Hematology.

[54]  Joseph S. Takahashi,et al.  Transcriptional architecture of the mammalian circadian clock , 2016, Nature Reviews Genetics.

[55]  Marius Ilie,et al.  p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis , 2016, Genes & development.

[56]  Thomas M. Keane,et al.  Variation in olfactory neuron repertoires is genetically controlled and environmentally modulated , 2016, bioRxiv.

[57]  D. Stern,et al.  Transcriptional Profiles from Paired Normal Samples Offer Complementary Information on Cancer Patient Survival – Evidence from TCGA Pan-Cancer Data , 2016, Scientific Reports.

[58]  L. Stein,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic Acids Res..

[59]  Trey Ideker,et al.  Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types , 2015, PloS one.

[60]  M. Qadir,et al.  Cdc42: Role in Cancer Management , 2015, Chemical biology & drug design.

[61]  Gregor Eichele,et al.  Synchronization of the mammalian circadian timing system: Light can control peripheral clocks independently of the SCN clock , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[62]  J. Snowden,et al.  The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours , 2015, British Journal of Cancer.

[63]  Subha Madhavan,et al.  The CPTAC Data Portal: A Resource for Cancer Proteomics Research. , 2015, Journal of proteome research.

[64]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[65]  M. McCarthy,et al.  RNA Sequencing Identifies Dysregulation of the Human Pancreatic Islet Transcriptome by the Saturated Fatty Acid Palmitate , 2014, Diabetes.

[66]  Mehdi Mesri,et al.  Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. , 2013, Cancer discovery.

[67]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[68]  J. Giebultowicz,et al.  Circadian Regulation of Glutathione Levels and Biosynthesis in Drosophila melanogaster , 2012, PloS one.

[69]  J. Hogenesch,et al.  Intracellular and intercellular processes determine robustness of the circadian clock , 2011, FEBS letters.

[70]  Yosef Yarden,et al.  Roles for growth factors in cancer progression. , 2010, Physiology.

[71]  H. Claésson,et al.  On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. , 2009, Prostaglandins & other lipid mediators.

[72]  Kenneth H. Buetow,et al.  PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..

[73]  D. Levy,et al.  JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.

[74]  Stephanie Kreis,et al.  Jaks and cytokine receptors--an intimate relationship. , 2006, Biochemical pharmacology.

[75]  G. Babcock,et al.  Oncogenic RAS Induces Accelerated Transition through G2/M and Promotes Defects in the G2 DNA Damage and Mitotic Spindle Checkpoints* , 2006, Journal of Biological Chemistry.

[76]  R. Terns,et al.  Telomerase RNA accumulates in Cajal bodies in human cancer cells. , 2003, Molecular biology of the cell.

[77]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[78]  S. Bhattacharya,et al.  Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.

[79]  T. Hofmann,et al.  Tyrosine-phosphorylated Vav1 as a Point of Integration for T-cell Receptor- and CD28-mediated Activation of JNK, p38, and Interleukin-2 Transcription* 210 , 2000, The Journal of Biological Chemistry.

[80]  I. Kerr,et al.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop , 1997, Molecular and cellular biology.

[81]  Nicolas Borisov,et al.  Using proteomic and transcriptomic data to assess activation of intracellular molecular pathways. , 2021, Advances in protein chemistry and structural biology.

[82]  Nicolas Borisov,et al.  Quantitation of Molecular Pathway Activation Using RNA Sequencing Data. , 2020, Methods in molecular biology.

[83]  Ethan D Buhr,et al.  Molecular components of the Mammalian circadian clock. , 2013, Handbook of experimental pharmacology.

[84]  D. Nie,et al.  Growth factors in tumor microenvironment. , 2010, Frontiers in bioscience.

[85]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..